Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference

Key Takeaway: Johnson & Johnson will participate in the Bernstein’s 42nd Annual Strategic Decisions Conference. The event aims to discuss strategic decisions within the biopharma industry. Further details about the topics to be covered or key speakers have not been provided.